← Leaderboards
Stewart Levine
National Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaLungMediatingPathway InteractionsPathogenesisPyroglyphidaeCellsExtrinsic AsthmaCaringProtocols DocumentationAirway InflammationAirway HyperresponsivenessEpithelial CellsAsthmaticGenesAdrenal Cortex HormonesApolipoprotein EAttenuatedEosinophilApolipoproteinsKnockout MiceInsightPharmaceutical PreparationsApolipoprotein A-I
Grant awards (117)
Pulmonary clinical medicine: PFT lab, bronchoscopy, consultation services, and education$1,470,372
ZID · FY2024 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$1,217,494
ZIA · FY2024 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$1,180,600
ZIA · FY2024 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$1,106,813
ZIA · FY2024 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$1,878,009
ZIA · FY2023 · HL · contact PI
Pulmonary clinical medicine: PFT lab, bronchoscopy, consultation services, and education$1,749,780
ZID · FY2023 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$1,707,281
ZIA · FY2023 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$640,230
ZIA · FY2023 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$42,682
ZIA · FY2023 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$1,581,761
ZIA · FY2022 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$1,520,323
ZIA · FY2022 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$570,121
ZIA · FY2022 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$38,008
ZIA · FY2022 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$38,008
ZIA · FY2022 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$2,311,146
ZIA · FY2021 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$733,697
ZIA · FY2021 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$550,273
ZIA · FY2021 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$36,685
ZIA · FY2021 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$36,685
ZIA · FY2021 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$2,175,856
ZIA · FY2020 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$530,330
ZIA · FY2020 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$530,330
ZIA · FY2020 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$176,777
ZIA · FY2020 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$35,355
ZIA · FY2020 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$35,355
ZIA · FY2020 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$1,615,360
ZIA · FY2019 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$607,852
ZIA · FY2019 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$319,993
ZIA · FY2019 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$176,063
ZIA · FY2019 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$176,063
ZIA · FY2019 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$176,063
ZIA · FY2019 · HL · contact PI
Asthma Sample Collection Protocol: Defining the Role of Apolipoprotein Pathways in Asthma$1,503,104
ZIA · FY2018 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$586,044
ZIA · FY2018 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$433,200
ZIA · FY2018 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$127,513
ZIA · FY2018 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$127,513
ZIA · FY2018 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$127,513
ZIA · FY2018 · HL · contact PI
Fiberoptic Bronchoscopy in Patients with Asthma$1,173,590
ZIA · FY2017 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$665,187
ZIA · FY2017 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$493,719
ZIA · FY2017 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$325,251
ZIA · FY2017 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$168,784
ZIA · FY2017 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$168,784
ZIA · FY2017 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$168,784
ZIA · FY2017 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$168,784
ZIA · FY2017 · HL · contact PI
Fiberoptic Bronchoscopy in Patients with Asthma$1,062,316
ZIA · FY2016 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$607,038
ZIA · FY2016 · HL · contact PI
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis$455,278
ZIA · FY2016 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$303,519
ZIA · FY2016 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$151,759
ZIA · FY2016 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$151,759
ZIA · FY2016 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$151,759
ZIA · FY2016 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$151,759
ZIA · FY2016 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$245,122
ZIA · FY2015 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$245,122
ZIA · FY2015 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$245,122
ZIA · FY2015 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$245,122
ZIA · FY2015 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$245,122
ZIA · FY2015 · HL · contact PI
Fiberoptic Bronchoscopy in Patients with Asthma$245,122
ZIA · FY2015 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$245,122
ZIA · FY2015 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$245,122
ZIA · FY2015 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$245,122
ZIA · FY2015 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$245,122
ZIA · FY2015 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$709,075
ZIA · FY2014 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$354,537
ZIA · FY2014 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$354,537
ZIA · FY2014 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$354,537
ZIA · FY2014 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$354,537
ZIA · FY2014 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$354,537
ZIA · FY2014 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$354,537
ZIA · FY2014 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$354,537
ZIA · FY2014 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$354,537
ZIA · FY2014 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$642,009
ZIA · FY2013 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$482,980
ZIA · FY2013 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$482,980
ZIA · FY2013 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$328,659
ZIA · FY2013 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$328,659
ZIA · FY2013 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$328,659
ZIA · FY2013 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$323,951
ZIA · FY2013 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$164,921
ZIA · FY2013 · HL · contact PI
Longitudinal Observational Study of Severe Asthma$164,921
ZIA · FY2013 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$455,780
ZIA · FY2012 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$455,780
ZIA · FY2012 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$455,780
ZIA · FY2012 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$303,853
ZIA · FY2012 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$303,853
ZIA · FY2012 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$303,853
ZIA · FY2012 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$303,853
ZIA · FY2012 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$303,853
ZIA · FY2012 · HL · contact PI
Regulation of Cytokine-Mediated Lung Inflammation$151,927
ZIA · FY2012 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$425,994
ZIA · FY2011 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$354,995
ZIA · FY2011 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$283,996
ZIA · FY2011 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$283,996
ZIA · FY2011 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$283,996
ZIA · FY2011 · HL · contact PI
Regulation of Cytokine-Mediated Lung Inflammation$283,996
ZIA · FY2011 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$283,996
ZIA · FY2011 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$283,996
ZIA · FY2011 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$283,996
ZIA · FY2011 · HL · contact PI
ID of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients$70,999
ZIA · FY2011 · HL · contact PI
Development of Apolipoprotein-based Therapeutics for Asthma$526,154
ZIA · FY2010 · HL · contact PI
Identifying and Characterizing "Corticosteroid-unresponsive" Genes in Asthma$450,989
ZIA · FY2010 · HL · contact PI
Regulation of Cytokine-Mediated Lung Inflammation$300,660
ZIA · FY2010 · HL · contact PI
Defining Apolipoprotein-mediated Regulatory Pathways in Asthmatic Airways$300,660
ZIA · FY2010 · HL · contact PI
Identification and Characterization of microRNA Genes in Asthma$300,660
ZIA · FY2010 · HL · contact PI
Characterization of the Role of NUCB2 in Asthma Pathogenesis$300,660
ZIA · FY2010 · HL · contact PI
Identifying New Therapeutic Approaches for Asthma$300,660
ZIA · FY2010 · HL · contact PI
Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma$300,660
ZIA · FY2010 · HL · contact PI
Characterizing the Role of Apolipoprotein Receptors in Asthma Pathogenesis$150,330
ZIA · FY2010 · HL · contact PI
ID of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients$75,165
ZIA · FY2010 · HL · contact PI
Mechanisms of Asthma Pathogenesis and Treatment$1,511,242
ZIA · FY2009 · HL · contact PI
Regulation of Cytokine-Mediated Lung Inflammation$418,992
ZIA · FY2009 · HL · contact PI
ID of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients$418,992
ZIA · FY2009 · HL · contact PI
Study of Pioglitazone Hydrochloride in Allergic Asthma$418,992
ZIA · FY2009 · HL · contact PI
Mechanisms of Asthma Pathogenesis and Treatment$610,017
Z01 · FY2008 · HL · contact PI
ID of Biomarkers in Exhaled Breath Condensates from Asthmatic Patients$261,436
Z01 · FY2008 · HL · contact PI
Study of Pioglitazone Hydrochloride in Allergic Asthma$261,436
Z01 · FY2008 · HL · contact PI